| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cytochrome P450 family 21 subfamily A member 2 | 0.525 | 0.769 | 2.6E-04 |
|
disease | 0.100 | None | 0.959 | 146 | 20 | 1980 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.100 | None | 0.976 | 42 | 1 | 1980 | 2019 | ||||||||
|
cytochrome P450 family 21 subfamily A member 1, pseudogene | 0.780 | 0.500 |
|
disease | 0.100 | None | 1.000 | 11 | 0 | 1991 | 2012 | |||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1978 | 1990 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2008 | 2016 | ||||||||
|
complement C4B (Chido blood group) | 0.603 | 0.808 | 0.83 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1986 | 1995 | ||||||||
|
cytochrome P450 family 2 subfamily B member 6 | 0.428 | 0.846 | 1.9E-10 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2005 | 2009 | ||||||||
|
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.582 | 0.500 | 7.2E-08 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2007 | 2015 | ||||||||
|
glyoxalase I | 0.537 | 0.769 | 9.7E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1978 | 1983 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.030 | None | 0.667 | 3 | 6 | 2005 | 2019 | ||||||||
|
dickkopf WNT signaling pathway inhibitor 1 | 0.439 | 0.885 | 0.17 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.020 | None | 1.000 | 2 | 1 | 2006 | 2012 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2009 | 2016 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2017 | ||||||||
|
chromodomain helicase DNA binding protein 7 | 0.441 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
bromodomain containing 2 | 0.450 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1993 | 1993 | ||||||||
|
cripto, FRL-1, cryptic family 1 | 0.588 | 0.577 | 0.11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1981 | 1981 | ||||||||
|
azoospermia factor 1 | 0.711 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | |||||||||
|
tripartite motif containing 27 | 0.572 | 0.808 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1990 | 1990 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | |||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
nuclear receptor subfamily 1 group I member 2 | 0.418 | 0.846 | 7.3E-09 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
aldo-keto reductase family 1 member C3 | 0.529 | 0.769 | 7.6E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 |